» Articles » PMID: 34606989

The COVID-19 Self-Testing Through Rapid Network Distribution (C-STRAND) Trial: A Randomized Controlled Trial to Increase COVID-19 Testing in Underserved Populations

Overview
Publisher Elsevier
Date 2021 Oct 4
PMID 34606989
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background Widely available population testing is critical to public health efforts to control the ongoing COVID-19 pandemic. However, COVID-19 testing has been low in underserved communities disproportionately affected by COVID-19. One approach to increase testing rates is through the secondary distribution of self-collection kits, where an individual distributes test kits to contacts in their social network and encourages them to self-collect test specimens. We outline a randomized clinical trial, COVID-19 Self-testing Through Rapid Network Distribution (C-STRAND), and a cohort study of individuals with COVID-19, to determine the impact of a secondary distribution strategy on COVID-19 testing among medically underserved populations. Methods The clinical trial will seek to enroll 1048 adult index participants from federally health qualified centers in Philadelphia, PA seeking COVID-19 testing. Eligible participants will be randomized 1:1 to receive multiple self-collection test kits or multiple referrals for standard clinic-based tests to distribute to contacts within their social network. The primary outcome will be testing among at least two network contacts at 8 weeks. Index participants and network contacts who test positive for COVID-19 from C-STRAND will be eligible to join the COVID-19 Close Contact Self-testing Study (CloseST), assessing the secondary distribution of self-collection test kits among individuals with COVID-19. The primary outcome of this cohort will be the number of close contacts who test positive at 8 weeks. Conclusion Novel strategies to promote COVID-19 testing are necessary, particularly among underserved populations most affected by COVID-19. We will determine the efficacy of a self-testing secondary distribution strategy. The results may inform efforts to increase testing rates during the current pandemic.

Citing Articles

Salient beliefs related to secondary distribution of COVID-19 self-test kits within social networks.

Bien-Gund C, Sarbaugh M, Perrine L, Dugosh K, Gross R, Fishman J Front Public Health. 2024; 12:1337745.

PMID: 38476496 PMC: 10927981. DOI: 10.3389/fpubh.2024.1337745.


Self-tests for COVID-19: What is the evidence? A living systematic review and meta-analysis (2020-2023).

Anand A, Vialard F, Esmail A, Khan F, OByrne P, Routy J PLOS Glob Public Health. 2024; 4(2):e0002336.

PMID: 38324519 PMC: 10849237. DOI: 10.1371/journal.pgph.0002336.


COVID-19 Testing Among People with HIV: A Population Level Analysis Based on Statewide Data in South Carolina.

Shi F, Zhang J, Yang X, Gao H, Chen S, Weissman S AIDS Behav. 2023; 28(Suppl 1):22-32.

PMID: 38109020 DOI: 10.1007/s10461-023-04244-4.


The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.

Qasmieh S, Robertson M, Teasdale C, Kulkarni S, Jones H, Larsen D Commun Med (Lond). 2023; 3(1):92.

PMID: 37391483 PMC: 10313770. DOI: 10.1038/s43856-023-00321-w.

References
1.
Lieberman-Cribbin W, Tuminello S, Flores R, Taioli E . Disparities in COVID-19 Testing and Positivity in New York City. Am J Prev Med. 2020; 59(3):326-332. PMC: 7316038. DOI: 10.1016/j.amepre.2020.06.005. View

2.
Lightfoot M, Campbell C, Moss N, Treves-Kagan S, Agnew E, Kang Dufour M . Using a Social Network Strategy to Distribute HIV Self-Test Kits to African American and Latino MSM. J Acquir Immune Defic Syndr. 2018; 79(1):38-45. DOI: 10.1097/QAI.0000000000001726. View

3.
Mody A, Pfeifauf K, Bradley C, Fox B, Hlatshwayo M, Ross W . Understanding Drivers of Coronavirus Disease 2019 (COVID-19) Racial Disparities: A Population-Level Analysis of COVID-19 Testing Among Black and White Populations. Clin Infect Dis. 2020; 73(9):e2921-e2931. PMC: 7799327. DOI: 10.1093/cid/ciaa1848. View

4.
Bagcchi S . Stigma during the COVID-19 pandemic. Lancet Infect Dis. 2020; 20(7):782. PMC: 7314449. DOI: 10.1016/S1473-3099(20)30498-9. View

5.
Sotgiu G, Dobler C . Social stigma in the time of coronavirus disease 2019. Eur Respir J. 2020; 56(2). PMC: 7338401. DOI: 10.1183/13993003.02461-2020. View